AIM: To analyze cancer mortality trends in men in Central Serbia during 1985-2006 period. METHODS: Mortality rates and trends for the most frequent cancers in men (lung, stomach, colorectal, pancreatic, and prostate cancer) were calculated. Mortality rates for all cancers were adjusted by direct standardization. Percentage changes of the rates were calculated as the percentage difference between the rates of two successive years and then as a mean of these changes for the entire observed period. Trend lines were estimated using linear regression. RESULTS: Total cancer mortality in men increased, with mean percentage of annual changes being 1.53% (95% confidence interval [CI], -0.09-3.16). Lung, stomach, colorectal, pancreatic, and prostate cancers represented 58.1% and 61.6% of total cancer deaths in 1985 and 2006, respectively. Increasing trends were observed for all investigated cancers: mean annual percentage change for lung cancer was 2.31%(95% CI, 1.03-3.59), for colorectal cancer 2.23% (95% CI, -0.18-4.65), for prostate cancer 3.06% (95% CI, -2.07-8.18), and for pancreatic cancer 1.58% (95% CI, -2.17-5.32). Stomach cancer mortality significantly decreased in age groups 40-49 and 50-59 years. CONCLUSION: The most frequent cancers in men in Central Serbia, i.e., lung, colorectal, prostate, and pancreatic cancer, showed an increasing trend. Only stomach cancer mortality decreased over time.
AIM: To analyze cancer mortality trends in men in Central Serbia during 1985-2006 period. METHODS: Mortality rates and trends for the most frequent cancers in men (lung, stomach, colorectal, pancreatic, and prostate cancer) were calculated. Mortality rates for all cancers were adjusted by direct standardization. Percentage changes of the rates were calculated as the percentage difference between the rates of two successive years and then as a mean of these changes for the entire observed period. Trend lines were estimated using linear regression. RESULTS: Total cancer mortality in men increased, with mean percentage of annual changes being 1.53% (95% confidence interval [CI], -0.09-3.16). Lung, stomach, colorectal, pancreatic, and prostate cancers represented 58.1% and 61.6% of total cancer deaths in 1985 and 2006, respectively. Increasing trends were observed for all investigated cancers: mean annual percentage change for lung cancer was 2.31%(95% CI, 1.03-3.59), for colorectal cancer 2.23% (95% CI, -0.18-4.65), for prostate cancer 3.06% (95% CI, -2.07-8.18), and for pancreatic cancer 1.58% (95% CI, -2.17-5.32). Stomach cancer mortality significantly decreased in age groups 40-49 and 50-59 years. CONCLUSION: The most frequent cancers in men in Central Serbia, i.e., lung, colorectal, prostate, and pancreatic cancer, showed an increasing trend. Only stomach cancer mortality decreased over time.
Authors: P Boyle; P Autier; H Bartelink; J Baselga; P Boffetta; J Burn; H J G Burns; L Christensen; L Denis; M Dicato; V Diehl; R Doll; S Franceschi; C R Gillis; N Gray; L Griciute; A Hackshaw; M Kasler; M Kogevinas; S Kvinnsland; C La Vecchia; F Levi; J G McVie; P Maisonneuve; J M Martin-Moreno; J Newton Bishop; F Oleari; P Perrin; M Quinn; M Richards; U Ringborg; C Scully; E Siracka; H Storm; M Tubiana; T Tursz; U Veronesi; N Wald; W Weber; D G Zaridze; W Zatonski; H zur Hausen Journal: Ann Oncol Date: 2003-07 Impact factor: 32.976
Authors: B Adanja; Z Gledovic; T Pekmezovic; H Vlajinac; M Jarebinski; V Zivaljevic; M Pavlovic Journal: Dig Liver Dis Date: 2000 Jun-Jul Impact factor: 4.088
Authors: Henrike E Karim-Kos; Esther de Vries; Isabelle Soerjomataram; Valery Lemmens; Sabine Siesling; Jan Willem W Coebergh Journal: Eur J Cancer Date: 2008-02-14 Impact factor: 9.162
Authors: M J Quinn; A d'Onofrio; B Møller; R Black; C Martinez-Garcia; H Møller; M Rahu; C Robertson; L J Schouten; C La Vecchia; P Boyle Journal: Ann Oncol Date: 2003-07 Impact factor: 32.976
Authors: P Boyle; U Veronesi; M Tubiana; F E Alexander; F da Silva; L J Denis; J M Freire; M Hakama; A Hirsch; R Kroes Journal: Eur J Cancer Date: 1995 Impact factor: 9.162
Authors: A Carrato; A Falcone; M Ducreux; J W Valle; A Parnaby; K Djazouli; K Alnwick-Allu; A Hutchings; C Palaska; I Parthenaki Journal: J Gastrointest Cancer Date: 2015-09